dextrothyroxine has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, A; Hu, L; Li, L; Li, Y; Liang, H; Liu, J; Qu, B; Song, D; Zhang, X; Zhang, Y | 1 |
| Choi, EY; Hong, JH; Jin, X; Jung, JE; Kim, H; Kim, JH; Kim, TH; Kim, YJ; Lee, JE; Lee, SH; Park, G; Park, JB; Park, JY; Park, N; Shin, D; Yin, J; Yoo, H | 1 |
2 other study(ies) available for dextrothyroxine and Brain Neoplasms
| Article | Year |
|---|---|
Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Glioma; Heterografts; Humans; Ivermectin; Mice; Mice, Inbred BALB C; Mice, Nude; Rats; Tumor Burden | 2019 |
DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.
Topics: Animals; Antiparasitic Agents; Brain Neoplasms; Cell Line; Cell Proliferation; Databases, Factual; DEAD-box RNA Helicases; Glioma; Green Fluorescent Proteins; Humans; Immunoprecipitation; In Situ Nick-End Labeling; Ivermectin; Mice; MicroRNAs; RNA, Small Interfering; Transduction, Genetic; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |